Zheng Quan Ri Bao Wang·2025-09-24 08:40Core Viewpoint - The company is committed to the inheritance and innovation of traditional Chinese medicine, actively advancing the research and development of innovative traditional Chinese medicine products and the secondary development of key varieties [1] Group 1: R&D Initiatives - The company is focusing on the modernization of classic formulas in the chronic disease field [1] - The company is exploring partnerships with research institutions in the classic formula area to promote project collaboration [1] Group 2: Strategic Partnerships - The company has established a strategic cooperation with Shantou University Medical College to jointly conduct new drug development and related basic and clinical research [1] - This partnership aims to accelerate the progress of innovative traditional Chinese medicine research and development [1]